BG28847A3 - Method of obtaining of hydantion derivatives - Google Patents

Method of obtaining of hydantion derivatives

Info

Publication number
BG28847A3
BG28847A3 BG7737604A BG3760477A BG28847A3 BG 28847 A3 BG28847 A3 BG 28847A3 BG 7737604 A BG7737604 A BG 7737604A BG 3760477 A BG3760477 A BG 3760477A BG 28847 A3 BG28847 A3 BG 28847A3
Authority
BG
Bulgaria
Prior art keywords
hydantion
derivatives
obtaining
hydantion derivatives
Prior art date
Application number
BG7737604A
Other languages
Bulgarian (bg)
English (en)
Inventor
Sarges
Original Assignee
Pfizer Inc.,Us
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/767,803 external-priority patent/US4117230A/en
Application filed by Pfizer Inc.,Us filed Critical Pfizer Inc.,Us
Publication of BG28847A3 publication Critical patent/BG28847A3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/10—Spiro-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Ophthalmology & Optometry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
BG7737604A 1976-10-18 1977-10-18 Method of obtaining of hydantion derivatives BG28847A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73306276A 1976-10-18 1976-10-18
US05/767,803 US4117230A (en) 1976-10-18 1977-02-11 Hydantoin derivatives as therapeutic agents

Publications (1)

Publication Number Publication Date
BG28847A3 true BG28847A3 (en) 1980-07-15

Family

ID=27112515

Family Applications (1)

Application Number Title Priority Date Filing Date
BG7737604A BG28847A3 (en) 1976-10-18 1977-10-18 Method of obtaining of hydantion derivatives

Country Status (29)

Country Link
JP (3) JPS5353653A (no)
AR (1) AR220901A1 (no)
AT (1) AT356136B (no)
AU (1) AU504978B2 (no)
BG (1) BG28847A3 (no)
CA (1) CA1088945A (no)
CH (1) CH625511A5 (no)
DD (1) DD131931A5 (no)
DE (4) DE2759927C2 (no)
DK (1) DK150302C (no)
ES (1) ES463267A1 (no)
FI (1) FI62307C (no)
FR (1) FR2367754A1 (no)
GB (1) GB1566171A (no)
GR (1) GR70201B (no)
HK (1) HK53881A (no)
IE (1) IE45805B1 (no)
IL (1) IL53094A0 (no)
KE (1) KE3167A (no)
LU (1) LU78330A1 (no)
MX (1) MX4899E (no)
MY (1) MY8200157A (no)
NL (1) NL167434C (no)
NO (1) NO148453C (no)
NZ (1) NZ185358A (no)
PH (1) PH15639A (no)
PT (1) PT67164B (no)
SE (1) SE437024B (no)
YU (1) YU40821B (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4130714A (en) * 1977-05-23 1978-12-19 Pfizer Inc. Hydantoin therapeutic agents
US4127665A (en) * 1978-01-18 1978-11-28 Pfizer Inc. Thienohydantoin derivatives
US4147797A (en) * 1978-08-11 1979-04-03 Pfizer Inc. Spiro-furanohydantoin derivatives
US4200642A (en) * 1978-08-21 1980-04-29 Pfizer Inc. Spiro-oxazolidindiones
US4181728A (en) * 1978-11-16 1980-01-01 Pfizer Inc. Spiro-polycyclicimidazolidinedione derivatives
US4181729A (en) * 1979-03-21 1980-01-01 Pfizer Inc. Phenyl or phenoxy substituted spiro-imidazolidinedione derivatives
US4235911A (en) * 1979-06-13 1980-11-25 Pfizer Inc. Hydantoin derivatives
US4283409A (en) * 1979-10-29 1981-08-11 Pfizer Inc. Imidazolone derivatives
US4286098A (en) * 1980-03-28 1981-08-25 Pfizer Inc. Process for the preparation of chiral hydantoins
JPS5745185A (en) * 1980-07-21 1982-03-13 Eisai Co Ltd Hydantoin derivative and its preparation
EP0065392B1 (en) * 1981-05-13 1985-02-13 Imperial Chemical Industries Plc Pharmaceutical compositions containing spiro succinimide derivatives
JPS58213717A (ja) * 1982-01-20 1983-12-12 Eisai Co Ltd ヒダントイン誘導体を含有する治療用薬剤
JPS59500617A (ja) * 1982-04-15 1984-04-12 アルコン・ラボラトリ−ズ・インコ−ポレ−テッド ヒダントイン治療剤
HU193191B (en) * 1982-12-06 1987-08-28 Pfizer Process for preparing spiro-hetero-azolones
US4474967A (en) * 1983-04-27 1984-10-02 Pfizer Inc. 8-Deutero and 8-tritio-substituted derivatives of D-4S-6-fluoro-spiro-[chroman-4,4'-imidazolidine]-2',5'-dione
HU198051B (en) * 1984-10-30 1989-07-28 Pfizer Process for producing spiro square brackets open imidazolidine-4,5'(6h)-quinoline square brackets closed-2,5-dione derivatives
JPS61200991A (ja) * 1985-03-04 1986-09-05 Sanwa Kagaku Kenkyusho:Kk スピロ―３―ヘテロアゾリジン化合物、その製法及びそれを有効成分とする糖尿病合併症の予防及び治療剤
US4575507A (en) * 1985-05-29 1986-03-11 Pfizer Inc. Spiro-imidazolidines as aldose reductase inhibitors and their pharmaceutical use
JPS6357588A (ja) * 1986-08-28 1988-03-12 Sanwa Kagaku Kenkyusho Co Ltd ヒダントイン誘導体、その塩並びに該化合物を有効成分とする糖尿病合併症の予防及び治療剤
HU204832B (en) * 1987-09-04 1992-02-28 Pfizer Process for producing spiro-(imidazolidine-4,4'-pyrano/2,3-b/pyridine) derivatives and pharmaceutical compositions comprising same
GB2355264A (en) 1999-09-30 2001-04-18 Merck & Co Inc Spirohydantoin derivatives useful as alpha 1a adrenoceptor antagonists
AU2003225077A1 (en) 2002-04-18 2003-11-03 University Of Virginia Patent Foundation Novel sodium channel blockers
FR2955107B1 (fr) 2010-01-08 2012-03-02 Servier Lab Nouveaux derives thiochromanes, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB818724A (en) * 1956-10-18 1959-08-19 Ici Ltd Hydantoin derivatives
DE1135915B (de) * 1961-06-29 1962-09-06 Asta Werke Ag Chem Fab Verfahren zur Herstellung neuer, antikonvulsiv wirksamer Spirohydantoine
US3532744A (en) * 1967-07-28 1970-10-06 American Home Prod 1- and 2-amino substituted indane and tetralene carboxylic acids
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
DE2449030A1 (de) * 1974-10-11 1976-05-20 Schering Ag Neue pyridin-derivate
US4130714A (en) * 1977-05-23 1978-12-19 Pfizer Inc. Hydantoin therapeutic agents

Also Published As

Publication number Publication date
NZ185358A (en) 1979-06-08
NO773548L (no) 1978-04-19
FI773060A (fi) 1978-04-19
CH625511A5 (en) 1981-09-30
KE3167A (en) 1981-11-06
NO148453C (no) 1983-10-12
DD131931A5 (de) 1978-08-09
JPS607997B2 (ja) 1985-02-28
YU244277A (en) 1982-08-31
GB1566171A (en) 1980-04-30
FR2367754A1 (fr) 1978-05-12
IE45805B1 (en) 1982-12-01
DE2759542C2 (no) 1988-07-07
PH15639A (en) 1983-03-11
DK150302B (da) 1987-02-02
LU78330A1 (fr) 1979-06-01
DE2746244A1 (de) 1978-04-20
JPS5495570A (en) 1979-07-28
ATA745977A (de) 1979-09-15
MX4899E (es) 1982-12-14
DK461377A (da) 1978-04-19
FI62307C (fi) 1982-12-10
GR70201B (no) 1982-08-31
JPS5534132B2 (no) 1980-09-04
NL7711358A (nl) 1978-04-20
FR2367754B1 (no) 1982-07-09
JPS5495575A (en) 1979-07-28
ES463267A1 (es) 1978-07-16
PT67164B (en) 1979-03-20
DE2746244C2 (de) 1983-05-19
YU40821B (en) 1986-06-30
FI62307B (fi) 1982-08-31
DE2759543C2 (no) 1987-04-09
AT356136B (de) 1980-04-10
SE437024B (sv) 1985-02-04
AU2943177A (en) 1979-04-12
DE2759927C2 (de) 1986-12-04
NO148453B (no) 1983-07-04
CA1088945A (en) 1980-11-04
JPS5940388B2 (ja) 1984-09-29
HK53881A (en) 1981-11-13
MY8200157A (en) 1982-12-31
JPS5353653A (en) 1978-05-16
NL167434C (nl) 1981-12-16
IE45805L (en) 1978-04-18
PT67164A (en) 1977-11-01
AU504978B2 (en) 1979-11-01
DK150302C (da) 1987-09-28
AR220901A1 (es) 1980-12-15
NL167434B (nl) 1981-07-16
IL53094A0 (en) 1977-12-30
SE7711053L (sv) 1978-04-19

Similar Documents

Publication Publication Date Title
BG28052A4 (en) Method of obtaining of aminoalkyl-heterocycles
BG28847A3 (en) Method of obtaining of hydantion derivatives
BG24673A3 (en) Method of obtaining quinazone derivatives
BG28061A3 (en) Method of obtaining of hexahydrodibenzopyranones
BG33153A3 (en) Method for obtaining of 1- aryloxy- 2- hydroxy- 3- alkylene
BG27554A3 (en) Method of obtaining of derivatives of 2- aroyl- 3- phenyl- bewzothiophenes
BG27734A3 (en) Method of obtaining of m- aryloxybenzaldehydes
BG28068A3 (en) Method of obtaining of 3-chlorcephalosporines
BG28072A4 (en) Method of obtaining of 1-substitvated canamyzine derivatives
BG28988A4 (en) Method of obtaining of 4- halo- dihydropropyrans
BG28071A3 (en) Method of obtaining of 2-deoxystreptamineaminoglucosides
BG27754A3 (en) Method of obtaining of 3- halomethylcephems
BG28055A3 (en) Method of obtaining of phenylperazine derivatives
BG28845A3 (en) Method of obtaining of n- alkyldiphenylamines
BG28066A3 (en) Method of obtaining of pyridobenzodiazepinones
GR59194B (en) Preparation method of aryloxy-1 amino-3-propanols-2
BG27755A3 (en) Method of obtaining of 7- alkoxy- 3- chlormethilcephems
BG27555A3 (en) Method of obtaining of derivatives of aroyl- phenilnaphtalenes
BG28417A3 (en) Method of obtaining of trans- 5a- aryldecahydrobenzazepine
BG31074A3 (en) Method for obtaining of 1- oxadethiacefalosporine
BG31363A3 (en) Method for obtaining of haloacetamid
JPS52121933A (en) Method of embanking
GR63598B (en) Method of preparation of n-6-chloranicotinoylo-ocmocisteino-thiolactone
JPS5350169A (en) Preparation method of tetrazols
JPS52108937A (en) Method of polybrominating bissphenoxyalkane